Aceto moves further into finished products with Rising acquisition
This article was originally published in Scrip
Executive Summary
The US pharmaceuticals and chemicals trading and distribution company Aceto has completed its acquisition of Rising Pharmaceuticals for $80 million, marking a step away from its traditional focus on active pharmaceutical ingredients.